• E2 Raises $80M in Series C Funding to Advance Pulmonary Embolism Treatment
415 Capital - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    212 followers

  • Elon Musk

    Elon Musk

    81 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    59 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    214 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
Home415 Capital
415 Capital logo

415 Capital

0 followers

About 415 Capital

415 Capital is a specialist venture capital firm focused on funding breakthrough and life-saving medical innovation. Based in Munich, Germany, the team supports clinical-stage and growth-stage medical technology companies with capital, expertise, and market access accrued over more than 25 years. The firm emphasizes investment strategy and value creation through its clinical network and partnership with medical practitioners and researchers.

Recent News

No recent news for this company.

Recent Deals

E2 Raises $80M in Series C Funding to Advance Pulmonary Embolism Treatment

April 7, 2026

Key Team Members

Michael Braun

Senior Venture Partner

Key Facts

HQ Location

Munich, Germany

Employees

11 - 50

Status

Investor

Investor Type

Venture Investor

Website

https://415capital.com